New research shows that natural mushroom extracts may have unique therapeutic effects compared to synthesized psilocybin.
Read morePsychedelics, Alzheimer’s Disease and Related Dementias
Psychedelics may have a role in treating Alzheimer’s disease and related dementias.
Read the latest research insights and treatment approaches.
Read morePhantom Pain and Psilocybin
Phantom pain and psilocybin are a growing area of research.
Psilocybin may be a treatment for this debilitating condition in the future.
Read morePsilocybin for Anxiety
Also the trial’s rate of full remission, or a full cessation of symptoms, was five times greater than the placebo group, a marked and compelling difference in treatment outcomes.
Read moreSerotonin Toxicity, Psilocybin and Anti-depressants
In a case report published in the journal Primary Care Companion to Central Nervous System Disorders, three Penn State clinicians describe a patient who experienced serotonin toxicity after combining antidepressants and anti-anxiety medications and psilocybin.
Serotonin toxicity, or serotonin syndrome, occurs when high levels of serotonin build up on the body; the condition can be fatal.
Read moreThe Benefits of Psilocybin
Small clinical trials have shown that one or two doses of psilocybin, given in a therapeutic setting, can make dramatic and long-lasting changes in people suffering from treatment-resistant major depressive disorder, which typically does not respond to traditional antidepressants.
Click here for the link to this article.
Read moreNext-Gen Psilocybin
CYB003 is a next-generation psilocybin designed to provide a faster onset of action and to reduce the duration of effects, ultimately thinning the financial barrier to access of this medicine in a medical setting.
The trial’s interim data demonstrated “rapid, robust, and clinically significant reduction of depression symptoms” three weeks after a single 12mg dose of CYB003.
Read morePsilocybin and Adverse Childhood Experiences
New Psilocybin Research
This recently published study showed that psilocybin use is associated with persisting improvements in mental health and wellbeing.
Read morePsilocybin, Cancer and Depression
This pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms.
Read more